Zoe Posner
Research and clinical development analyst with experience supporting biomedical research programs, translational science initiatives, and emerging therapeutic innovation.
Zoe Posner brings a strong foundation in molecular biology and translational biomedical research, with experience contributing to large-scale research initiatives focused on cancer biology and therapeutic resistance. Her work centers on analyzing complex biological data, supporting research program execution, and translating laboratory insights into structured scientific development frameworks.
Areas of Focus / Expertise
- Molecular and cellular biology research
- Translational science and therapeutic target discovery
- Oncology research and mechanisms of drug resistance
- Biomedical data analysis and research program support
- Scientific literature synthesis and research documentation
- Health equity and disparities in biomedical research
Selected Experience & Impact
Zoe has contributed to large collaborative research initiatives examining mechanisms of resistance to chemotherapeutic drugs in pediatric solid tumors as part of the Cancer Dependency Map project at the Broad Institute. Her academic research has also included work on targeted protein degradation strategies in molecular biology laboratories, supporting early-stage therapeutic discovery efforts.
Background & Credentials
Zoe is currently pursuing combined physician-scientist training in an MD-PhD program at the Yale School of Medicine. She earned a BS in Molecular, Cellular, and Developmental Biology from Yale University, where she conducted undergraduate thesis research on genetic strategies for targeted protein degradation.
Zoe is particularly interested in advancing translational research that addresses pediatric cancers and health disparities, with the goal of bridging laboratory discovery and clinical impact.